Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF

R&D Systems | Catalog # 3485-AN

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems NS0-derived Recombinant Human Angiopoietin-like 4 C-Terminal Frag (3485-AN)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

NS0

Accession Number

Q9BY76

Structure / Form

Oligomer

Applications

Inhibition Activity
View all Angiopoietin-like Protein 4/ANGPTL4 Proteins and Enzymes »

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human Angiopoietin-like Protein 4/ANGPTL4 protein
Leu165-Ser406, with a C-terminal 6-His tag

Purity

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Leu165

Predicted Molecular Mass

28 kDa

SDS-PAGE

36 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human Angiopoietin‑like 4/ANGPTL4 C‑Terminal Fragment is immobilized at 1 μg/mL, 100 μL/well, the concentration of Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera  (Catalog # 2078-T4) binds with an ED50 of 70.0-350 ng/mL.

Formulation, Preparation, and Storage

3485-AN
Formulation Lyophilized from a 0.2 μm filtered solution in Tris-Citrate and NaCl.
Reconstitution

Reconstitute at 250 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Angiopoietin-like Protein 4/ANGPTL4

ANGPT-L4, also known as FIAF, FARP, and PGAR, is a 55 kDa glycoprotein secreted by the liver and fat tissue that is structurally related to the angiopoietins. It contains an N‑terminal coiled coil domain and a C‑terminal fibrinogen-like domain which can be proteolytically separated in vivo (1, 2). Mature human ANGPT‑L4 shares 26%‑30% amino acid (aa) sequence identity with ANGPT-L1, 2, 3, 5, 6, and 7. It shares approximately 75% aa sequence identity with mouse and rat ANGPT‑L4. The coiled coil domain, which is not glycosylated, mediates the formation of variable sized disulfide-linked oligomers (3, 4). This domain directly inhibits lipoprotein lipase, resulting in increased circulating triglyceride levels (5-9). In human, the N-terminal fragment and full length ANGPT-L4 physically associate with HDL (9). In mouse, however, full length ANGPT-L4 associates with HDL, while the N-terminal fragment associates with LDL (9). Circulating ANGPT-L4 is decreased in type II diabetics with a subsequent loss of its normal plasma glucose lowering activity (10). Its expression in adipose tissue is induced by fasting and suppressed by feeding (3, 11). Its expression in both liver and fat is up‑regulated by PPAR alpha, beta, gamma, and delta agonists and down‑regulated by insulin (3, 12, 13). ANGPT-L4 is induced in vascular endothelial cells by hypoxia and in hypoxic areas surrounding tumors (14-16). The full length molecule but not the C-terminal fragment is bound by heparan sulfate proteoglycans and functions as an angiogenesis inhibitor (14, 15).

References

  1. Li, C. (2006) Curr. Opin. Lipidol. 17:152.
  2. Kersten, S. (2005) Biochem. Soc. Transact. 33:1059.
  3. Ge, H. et al. (2005) J. Lipid Res. 46:1484.
  4. Ge, H. et al. (2004) J. Biol. Chem. 279:2038.
  5. Sukonina, V. et al. (2006) Proc. Natl. Acad. Sci. 103:17450.
  6. Koster, A. et al. (2005) Endocrinology 146:4943.
  7. Yoshida, K. et al. (2002) J. Lipid Res. 43:1770.
  8. Ge, H. et al. (2004) J. Lipid Res. 45:2071.
  9. Mandard, S. et al. (2006) J. Biol. Chem. 281:934.
  10. Xu, A. et al. (2005) Proc. Natl. Acad. Sci. 102:6086.
  11. Kersten, S. et al. (2000) J. Biol. Chem. 275:28488.
  12. Mandard, S. et al. (2004) J. Biol. Chem. 279:34411.
  13. Yamada, T. et al. (2006) Biochem. Biophys. Res. Commun. 347:1138.
  14. Cazes, A. et al. (2006) Circ. Res. 99:1207.
  15. Le Jan, S. et al. (2003) Am. J. Pathol. 162:1521.
  16. Ito, Y. et al. (2003) Cancer Res. 63:6651.

Alternate Names

Angiopoietin like Protein 4, ANGPTL4, FIAF, HFARP, PGAR

Entrez Gene IDs

51129 (Human); 57875 (Mouse); 362850 (Rat)

Gene Symbol

ANGPTL4

UniProt

Q9BY76

Additional Angiopoietin-like Protein 4/ANGPTL4 Products

Product Documents for Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF

For research use only

Citations for Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF

Customer Reviews for Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF and earn rewards!

Have you used Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes